InvestorPlace - Stock Market News, Stock Advice & Trading Tips
ANVS stock closed up more than 75% today after Annovis announced encouraging clinical trial results for its Parkinson's drug, buntanetap.
The post Why Did Annovis Bio (ANVS) Stock Close Up 80% Today? appeared first on InvestorPlace.
More From InvestorPlace